The results of replacement arthroplasty in the treatment of bone chondrosarcoma

Authors

DOI:

https://doi.org/10.22141/1608-1706.2.22.2021.231958

Keywords:

chondrosarcoma, long bone, joint, replacement arthplasty

Abstract

This article reports on the results of replacement arthroplasty in the treatment of bone chondrosarcoma. As a result of replacement arthroplasty in 28 patients, post-surgical complications were observed in two (7.1 %) patients, and tumor recurrence was observed in two (7.1 %) patients. Infectious post-surgical complications were observed in one patient after replacement arthroplasty of coxofemoral joint; the endoprosthesis in this patient was removed, and cement spacer was implanted; six months later the replacement arthroplasty was repeated. The aseptic loosening of the endoprosthetic stem of the joint was observed in one patient after knee arthroplasty; the replacement arthroplasty was repeated. The chondrosarcoma recurrence was identified in two patients between 18 to 53 months; lower extremity amputation was performed in one patient at the level of the mid-third of the femur; lower extremity amputation was performed in one patient at the level of the lower third of the femur, and polychemotherapy courses, including further metastasectomy, were performed in three patients having dedifferentiated and mesenchymal chondrosarcoma with metastases in the lungs. The functional result in the extremity, depending on the tumor site (based on MSTS scoring system) after the endoprosthetic procedure constituted 68.4 to 89.2 %. The quality of life of patients, according to the EORTC QLQ-30 questionnaire, was 40–50 scores before the arthroplasty, while after the arthroplasty the score went up and constituted 85–90 on average. The overall three-year survival rate of patients with chondrosarcoma constituted 95.3 ± 1.7 % and the five-year survival rate was 89.7 ± 2.1 %. The survival rate for patients with mesenchymal and dedifferentiated chondrosarcoma constituted 0 %.

Downloads

Download data is not yet available.

References

Limaiem F., Davis D.D., Sticco K.L. Chondrosarcoma. 2020 Dec 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021 Jan. PMID: 30844159.

Chow W.A. Chondrosarcoma: biology, genetics, and epigenetics. F1000Res. 2018 Nov 20. 7. F1000 Faculty Rev-1826. doi: 10.12688/f1000research.15953.1. PMID: 30519452; PMCID: PMC6248264.

Karpik M., Reszeć J. Low Grade Chondrosarcoma — Epi-demiology, Diagnosis, Treatment. Ortop. Traumatol. Rehabil. 2018 Feb 27. 20(1). 65-70. doi: 10.5604/01.3001.0011.5879. PMID: 30152763.

Ferguson J.L., Turner S.P. Bone Cancer: Diagnosis and Treatment Principles. Am. Fam. Physician. 2018 Aug 15. 98(4). 205-213. PMID: 30215968.

Marco R.A., Gitelis S., Brebach G.T., Healey J.H. Cartilage tumors: evaluation and treatment. J. Am. Acad. Orthop. Surg. 2000 Sep-Oct. 8(5). 292-304. doi: 10.5435/00124635-200009000-00003. PMID: 11029557.

Ozaki T., Hillmann A., Lindner N., Blasius S., Winkelmann W. Metastasis of chondrosarcoma. J. Cancer Res. Clin. Oncol. 1996. 122(10). 625-8. PMID: 8879261.

MacDonald I.J., Lin C.Y., Kuo S.J., Su C.M., Tang C.H. An update on current and future treatment options for chondrosarcoma. Expert Rev. Anticancer Ther. 2019 Sep. 19(9). 773-786. doi: 10.1080/14737140.2019.1659731. Epub 2019 Sep 6. PMID: 31462102.

Campbell C.J. Indications and principles of amputation for bone sarcoma. Proc. Natl. Cancer Conf. 1970. 6. 757-67. PMID: 4917736.

Immenkamp M., Schilgen L., Hobik H.P. Die Indikation zur Amputation oder Resektion beim Chondrosarkom [Indications for amputation or resection in chondrosarcoma (proceedings)]. Z. Orthop. Ihre Grenzgeb. 1978 Aug. 116(4). 529. German. PMID: 706600.

Sanders P.T.J., Spierings J.F., Albergo J.I., Bus M.P.A., Fiocco M., Farfalli G.L., van de Sande M.A.J., Aponte-Tinao L.A., Dijkstra P.D.S. Long-Term Clinical Outcomes of Intercalary Allograft Reconstruction for Lower-Extremity Bone Tumors. J. Bone Joint Surg. Am. 2020 Jun 17. 102(12). 1042-1049. doi: 10.2106/JBJS.18.00893. PMID: 32265356.

Albergo J.I., Farfalli Luis G.L., Ayerza M.A., Muscolo D.L., Aponte-Tinao L.A. Proximal humerus chondrosarcoma.Long-term clinical and oncological outcomes. Rev. Esp. Cir. Ortop. Traumatol. 2019 May-Jun. 63(3). 181-186. English, Spanish. doi: 10.1016/j.recot.2019.01.002. Epub 2019 Mar 23. PMID: 30914237.

Дедков А.Г., Климнюк Г.И. Реконструкции диафизарных дефектов длинных костей при их поражении опухолями. Вісник ортопедії, травматології та протезування. 2010. 2. 36-42.

Климовицкий Ф.В., Бабоша В.А., Гребенюк Ю.А., Хасам Абу-Фаддех, Ютовец Ю.Г., Солоницын Е.А. Показания и противопоказания к эндопротезированию опухолевых дефектов костей коленного сустава. Травма. 2014. 15(4). 42-45.

Hardes J., Gosheger G., Budny T. Knochensarkome. Z. Orthop. Unfall. 2018 Feb. 156(1). 105-124. German. doi: 10.1055/s-0043-117905. Epub 2018 Feb 22. PMID: 29471560.

Andreou D., Henrichs M.P., Gosheger G., Nottrott M., Streitbürger A., Hardes J. Neue Operationsverfahren bei Knochentumoren [New surgical treatment options for bone tumors]. Pathologe. 2014 Nov. 35(Suppl. 2). 232-6. German. doi: 10.1007/s00292-014-2004-1. PMID: 25394971.

Barjaktarović R., Popović Z., Radoicié D. Megaendoprosthesis in the treatment of bone tumors in the knee and hip region. Vojnosanit Pregl. 2011 Jan. 68(1). 62-7. doi: 10.2298/vsp1101062b. PMID: 21417134.

Linares-González L.M., Rico-Martínez G., Dominguez-Hernández V.M., Araujo-Monsalvo V., Delgado-Cedillo E.A., León-Hernández S.R. Tratamiento y reconstrucción en tumores óseos del húmero con prótesis no convencional tipo RIMAG [Treatment and reconstruction of bone tumors of the with a RIMAG unconventional prosthesis]. Acta Ortop. Mex. 2014 Jan-Feb. 28(1). 3-11. Spanish. PMID: 26031131.

Zheng K., Yu X.C., Hu Y.C., Shao Z.W., Xu M., Wang B.C., Wang F. Outcome of segmental prosthesis reconstruction for diaphyseal bone tumors: a multi-center retrospective study. BMC Cancer. 2019 Jun 28. 19(1). 638. doi: 10.1186/s12885-019-5865-0. PMID: 31253134; PMCID: PMC6599373.

Amer K.M., Munn M., Congiusta D., Abraham J.A., Basu Mallick A. Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis. J. Orthop. Res. 2020 Feb. 38(2). 311-319. doi: 10.1002/jor.24463. Epub 2019 Sep 22. PMID: 31498474.

Fromm J., Klein A., Baur-Melnyk A., Knösel T., Lindner L., Birkenmaier C., Roeder F., Jansson V., Dürr H.R. Survival and prognostic factors in conventional G1 chondrosarcoma. World J. Surg. Oncol. 2019 Sep 3. 17(1). 155. doi: 10.1186/s12957-019-1695-4. PMID: 31481076; PMCID: PMC6724259.

Published

2021-10-05

How to Cite

Protsenko, V., Buryanov О., Obada, B., Solonitsyn, Y., & Litun, Y. (2021). The results of replacement arthroplasty in the treatment of bone chondrosarcoma. TRAUMA, 22(2), 41–46. https://doi.org/10.22141/1608-1706.2.22.2021.231958

Issue

Section

Original Researches

Most read articles by the same author(s)

1 2 3 > >>